LYRA

Stock ticker: NASDAQ

PRICE

CHANGE

CAPITALIZATION

Lyra Therapeutics (LYRA) Earnings Date & Reports

Lyra Therapeutics Inc is a clinical-stage therapeutics company focused on the development and commercialization of novel integrated drug and delivery solutions for the localized treatment of patients with ear, nose, and throat diseases... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

LYRA is expected to report earnings to fall 28.12% to -11 cents per share on May 13

Lyra Therapeutics LYRA Stock Earnings Reports

Q1'25

Est.

$-0.12

Q4'24

Beat

by $0.03

Q3'24

Beat

by $0.04

Q2'24

Missed

by $0.41

Q1'24

Missed

by $0.09

The last earnings report on March 13 showed earnings per share of -15 cents, beating the estimate of -19 cents. With 2.36M shares outstanding, the current market capitalization sits at 7.31M.

View a ticker or compare two or three

Compare

LYRA

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if bought

View Trends For LYRA
(Try 14 days for Free)

Ad is loading...

A.I.Advisor

published price charts

A.I. Advisor

published General Information

General Information

a clinical-stage therapeutics company, which develops novel integrated drug and delivery solutions for the localized treatment of patients with ear, nose and throat, or ENT, diseases

Industry Biotechnology

Profile

Fundamentals

Details

Industry

N/A

Address

480 Arsenal Way

Phone

+1 617 393-4600

Employees

145

Web

https://lyratherapeutics.com